razoxane has been researched along with Psoriasis in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (66.67) | 18.7374 |
| 1990's | 5 (18.52) | 18.2507 |
| 2000's | 1 (3.70) | 29.6817 |
| 2010's | 2 (7.41) | 24.3611 |
| 2020's | 1 (3.70) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, Y; Li, K; Zhang, J; Zhou, Y | 1 |
| Bian, S; Li, D; Mi, Y; Wang, J; Wang, Y; Xue, Y | 1 |
| Lacarrubba, F; Massimino, D; Micali, G; Musumeci, ML; Nasca, MR | 1 |
| Griffiths, WA; Levene, GM; Steinman, HK | 1 |
| Aresca, S; Fuente, G; Mom, A; Pecorini, V; Pellerano, G; Perez, V | 1 |
| Church, RE; Tucker, WF | 1 |
| Caffrey, EA; Clark, KG; Daker, MG; Horton, JJ; MacDonald, DM; Wells, RS | 1 |
| Horton, JJ; Wells, RS | 1 |
| Horton, JJ; MacDonald, DM; Wells, RS | 1 |
| Champion, RH | 1 |
| Abel, EA; Charuworn, A; Farber, EM | 1 |
| Copeman, PW; Harper, JI; Staughton, RC | 2 |
| Atherton, DJ | 1 |
| Atherton, DJ; Laurent, MR; Wells, RS; Williams, YF | 1 |
| Hill, GW; Roach, M | 1 |
| Li, XF; Tu, ZH; Ye, H | 1 |
| Gao, LS; Wang, XY; Zhang, MH | 1 |
| Guo, Y; Xie, X; Xue, Y | 1 |
| Evans, AV; Parker, JC; Russell-Jones, R | 1 |
| Atherton, DJ; Hellman, K; Wells, RS | 1 |
| Guo, Y; Lin, B; Lu, D; Xue, Y | 1 |
| Bale, G; Chesney, TM; Noah, PW; Rosenberg, EW; Skinner, RB; Xu, B | 1 |
| Aboud, H; Coulson, I; Powles, RL; Treleaven, JG; Zuiable, AG | 1 |
| Harper, JI; Langtry, JA; Mallett, RB; Staughton, RC | 1 |
| Caffrey, EA; Daker, MG; Horton, JJ | 1 |
| Griffiths, WA | 1 |
2 review(s) available for razoxane and Psoriasis
| Article | Year |
|---|---|
Cutaneous vascular patterns in psoriasis.
Topics: Cell Proliferation; Cholecalciferol; Cyclosporine; Cytokines; Humans; Keratinocytes; Microvessels; Neovascularization, Pathologic; Psoriasis; Razoxane; Retinoids; Skin | 2010 |
Psoriasis and its treatment.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anthralin; Humans; Hydroxyurea; Methotrexate; Middle Aged; Psoriasis; PUVA Therapy; Razoxane | 1981 |
25 other study(ies) available for razoxane and Psoriasis
| Article | Year |
|---|---|
Chronic myeloid leukaemia in a patient with psoriasis following bimolane treatment.
Topics: Antineoplastic Agents; Dermatologic Agents; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Psoriasis; Razoxane | 2020 |
Acute leukemia association with psoriasis: a report on 100 patients from a single center in China.
Topics: Adult; Aged; China; Cohort Studies; Disease-Free Survival; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Nuclear Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Promyelocytic Leukemia Protein; Psoriasis; Radiation-Sensitizing Agents; Razoxane; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Transcription Factors; Tumor Suppressor Proteins; Young Adult | 2010 |
Methotrexate in lieu of razoxane for incapacitating psoriasis.
Topics: Humans; Leukemia, Myeloid, Acute; Methotrexate; Piperazines; Psoriasis; Razoxane; Skin Neoplasms | 1984 |
Razoxane in the treatment of psoriatic patients resistant to or intolerant of PUVA, methotrexate and etretinate.
Topics: Adult; Aged; Drug Resistance; Etretinate; Female; Humans; Male; Methotrexate; Middle Aged; Piperazines; Psoriasis; PUVA Therapy; Razoxane | 1982 |
Beau's lines after razoxane therapy for psoriasis.
Topics: Aged; Humans; Male; Nail Diseases; Piperazines; Psoriasis; Razoxane | 1984 |
Leukaemia in psoriatic patients treated with razoxane.
Topics: Humans; Leukemia, Myeloid, Acute; Piperazines; Psoriasis; Razoxane | 1984 |
Razoxane: a review of 6 years' therapy in psoriasis.
Topics: Adult; Arthritis; Bone Marrow Diseases; Carcinoma, Squamous Cell; Humans; Leg Ulcer; Neutropenia; Piperazines; Psoriasis; Razoxane; Skin Neoplasms; Time Factors | 1983 |
Epitheliomas in patients receiving razoxane therapy for psoriasis.
Topics: Adult; Carcinoma, Squamous Cell; Humans; Male; Piperazines; Psoriasis; Razoxane; Skin Neoplasms | 1983 |
Recent advances in the treatment of psoriasis.
Topics: Anthralin; Coal Tar; Drug Therapy, Combination; Etretinate; Humans; Methotrexate; Psoriasis; PUVA Therapy; Razoxane; Tretinoin; Ultraviolet Therapy | 1983 |
Razoxane regimen for the treatment of psoriasis.
Topics: Adult; Female; Humans; Male; Piperazines; Psoriasis; Razoxane | 1982 |
Razoxane regimen for the treatment of psoriasis.
Topics: Adult; Drug Administration Schedule; Female; Humans; Piperazines; Psoriasis; Razoxane | 1982 |
Razoxane.
Topics: Humans; Piperazines; Psoriasis; Razoxane | 1981 |
Razoxane (ICRF 159) in the treatment of psoriasis.
Topics: Adult; Alopecia; Anemia; Arthritis; Bone Marrow Diseases; Female; Humans; Male; Middle Aged; Neutropenia; Piperazines; Psoriasis; Razoxane | 1980 |
Razoxane in the treatment of psoriasis.
Topics: Chemical and Drug Induced Liver Injury; Humans; Methotrexate; Piperazines; Psoriasis; Razoxane | 1980 |
[Leukemia associated with bimkolane].
Topics: Adolescent; Adult; Aged; Animals; Chromosome Aberrations; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Mice; Micronucleus Tests; Middle Aged; Psoriasis; Razoxane; Retrospective Studies | 1994 |
[140 cases of acute leukemia caused by bimolane].
Topics: Adult; Aged; Female; Humans; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Psoriasis; Razoxane; Retrospective Studies | 1993 |
Translocation t(7;11)(P15;P15) in a patient with therapy-related acute myeloid leukemia following bimolane and ICRF-154 treatment for psoriasis.
Topics: Acute Disease; Adult; Antineoplastic Agents; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 7; Humans; Karyotyping; Leukemia, Myeloid; Male; Neoplasms, Second Primary; Psoriasis; Razoxane; Translocation, Genetic | 1997 |
Erythrodermic psoriasis precipitated by radiologic contrast media.
Topics: Administration, Oral; Cecal Neoplasms; Contrast Media; Female; Humans; Immunosuppressive Agents; Infusions, Intravenous; Iopamidol; Liver Neoplasms; Middle Aged; Psoriasis; Razoxane; Tomography, X-Ray Computed | 2002 |
Razoxane (ICRF 159) in psoriasis.
Topics: Drug Evaluation; Humans; Piperazines; Psoriasis; Razoxane | 1976 |
Specific chromosomal translocations and therapy-related leukemia induced by bimolane therapy for psoriasis.
Topics: Adolescent; Adult; Humans; Karyotyping; Leukemia, Myeloid, Acute; Male; Middle Aged; Psoriasis; Razoxane; Translocation, Genetic; Treatment Outcome | 1992 |
Efficacy of bimolane in the Malassezia ovalis model of psoriasis.
Topics: Administration, Cutaneous; Administration, Oral; Animals; Betamethasone Valerate; Disease Models, Animal; Female; Injections, Intravenous; Malassezia; Methotrexate; Psoriasis; Rabbits; Razoxane; Skin | 1991 |
Razoxane and T-cell lymphoma.
Topics: Adult; Humans; Lymphoma, Non-Hodgkin; Male; Piperazines; Psoriasis; Razoxane; T-Lymphocytes | 1989 |
Psoriasis, razoxane and a cutaneous B-cell lymphoma.
Topics: Aged; B-Lymphocytes; Female; Humans; Lip Neoplasms; Lymphoma; Piperazines; Psoriasis; Razoxane | 1987 |
Acute myeloid leukaemia after treatment with razoxane.
Topics: Adult; Aged; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Piperazines; Prospective Studies; Psoriasis; Razoxane | 1985 |
Risk of leukemia associated with chemotherapy.
Topics: Humans; Leukemia, Myeloid, Acute; Male; Piperazines; Psoriasis; Razoxane; Risk | 1985 |